Discovery and structure-activity relationships of novel selective norepinephrine and dual serotonin/norepinephrine reuptake inhibitors

被引:30
|
作者
Boot, J
Cases, M
Clark, BP
Findlay, J
Gallagher, PT
Hayhurst, L
Man, T
Montalbetti, C
Rathmell, RE
Rudyk, H
Walter, MW
Whatton, M
Wood, V
机构
[1] Eli Lilly & Co, Lilly Res Ctr, Windlesham GU20 6PH, Surrey, England
[2] Evotec OAI, Abingdon OX14 4SD, Oxon, England
关键词
monoamine reuptake inhibitors; selective norepinephrine reuptake inhibitor; dual reuptake inhibitor; SAR; serotonin; norepinephrine;
D O I
10.1016/j.bmcl.2004.11.025
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Novel arylthiomethyl morpholines are potent selective norepinephrine reuptake inhibitors (NERIs) and dual serotonin/ norepinephrine reuptake inhibitors (SRI/NERIs). The target compounds were prepared using a stereochemically versatile synthesis featuring an aldol condensation as the key step. One enantiomer of the 2-methoxy-substituted analogue was found to be a potent and selective norepinephrine reuptake inhibitor, whereas the opposite enantiomer was a potent dual serotonin/norepinephrine reuptake inhibitor. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:699 / 703
页数:5
相关论文
共 50 条
  • [1] Structure-activity relationships of the cycloalkanol ethylamine scaffold: Discovery of selective norepinephrine reuptake inhibitors
    Mahaney, Paige E.
    Gavrin, Lori K.
    Trybulski, Eugene J.
    Stack, Gary P.
    Vu, An T.
    Cohn, Stephen T.
    Ye, Fei
    Belardi, Justin K.
    Santilli, Arthur A.
    Sabatucci, Joseph P.
    Leiter, Jennifer
    Johnston, Grace H.
    Bray, Jenifer A.
    Burroughs, Kevin D.
    Cosmi, Scott A.
    Leventhal, Liza
    Koury, Elizabeth J.
    Zhang, Yingru
    Mugford, Cheryl A.
    Ho, Douglas M.
    Rosenzweig-Lipson, Sharon J.
    Platt, Brian
    Smith, Valerie A.
    Deecher, Darlene C.
    JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (13) : 4038 - 4049
  • [2] Structure-activity relationships of chiral selective norepinephrine reuptake inhibitors (sNRI) with increased oxidative stability
    Hudson, Sarah
    Kiankarimi, Mehrak
    Eccles, Wendy
    Dwight, Wesley
    Mostofi, Yalda S.
    Genicot, Marc J.
    Fleck, Beth A.
    Gogas, Kathleen
    Aparicio, Anna
    Wang, Hua
    Wen, Jenny
    Wade, Warren S.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (16) : 4491 - 4494
  • [3] Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint
    Hudson, Sarah
    Kiankarimi, Mehrak
    Eccles, Wendy
    Mostofi, Yalda S.
    Genicot, Marc J.
    Dwight, Wesley
    Fleck, Beth A.
    Gogas, Kathleen
    Wade, Warren S.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (16) : 4495 - 4498
  • [4] Benzothienyloxy phenylpropanamines, novel dual inhibitors of serotonin and norepinephrine reuptake
    Boot, J. R.
    Brace, G.
    Fairhurst, J.
    Gallagher, P. T.
    Mitchell, S.
    Rathmell, R. E.
    Richards, S. J.
    Simmonds, R. G.
    Whatton, M. A.
    Boulet, S. L.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2004, 18 : 143 - 143
  • [5] Benzothienyloxy phenylpropanamines, novel dual inhibitors of serotonin and norepinephrine reuptake
    Boot, JR
    Brace, G
    Delatour, CL
    Dezutter, N
    Fairhurst, J
    Findlay, J
    Gallagher, PT
    Hoes, I
    Mahadevan, S
    Mitchell, SN
    Rathmell, RE
    Richards, SJ
    Simmonds, RG
    Wallace, L
    Whatton, MA
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (21) : 5395 - 5399
  • [6] Structure-activity relationships of norepinephrine reuptake inhibitors with benzothiadiazine dioxide or dihydrosulfostyril cores
    Fensome, Andrew
    Goldberg, Joel
    McComas, Casey C.
    Trybulski, Eugene J.
    Woodworth, Richard P.
    Deecher, Darlene C.
    Whiteside, Garth T.
    Zhang, Puwen
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (05) : 1555 - 1558
  • [7] Comparison of the effects of serotonin selective, norepinephrine selective, and dual serotonin and norepinephrine reuptake inhibitors on lower urinary tract function in cats
    Katofiasc, MA
    Nissen, J
    Audia, JE
    Thor, KB
    LIFE SCIENCES, 2002, 71 (11) : 1227 - 1236
  • [8] Discovery of a Potent, Dual Serotonin and Norepinephrine Reuptake Inhibitor
    Dreyfus, Nicolas
    Myers, Jason K.
    Badescu, Valentina O.
    de Frutos, Oscar
    Luz de la Puente, Maria
    Ding, Chunjin
    Filla, Sandra A.
    Fynboe, Karsten
    Gernert, Douglas L.
    Heinz, Beverly A.
    Hemrick-Luecke, Susan K.
    Johnson, Kirk W.
    Johnson, Michael P.
    Lopez, Pilar
    Love, Patrick L.
    Martin, Laura J.
    Masquelin, Thierry
    McCoy, Michael J.
    Mendiola, Javier
    Morrow, Denise
    Muhlhauser, Mark
    Pascual, Gustavo
    Perun, Thomas J.
    Pfeifer, Lance A.
    Phebus, Lee A.
    Richards, Simon J.
    Antonio Rincon, Juan
    Seest, Eric P.
    Shah, Jikesh
    Shaojuan, Jia
    Simmons, Rosa Maria A.
    Stephenson, Gregory A.
    Tromiczak, Eric G.
    Thompson, Linda K.
    Walter, Magnus W.
    Weber, Wayne W.
    Zarrinmayeh, Hamideh
    Thomas, Craig E.
    Joshi, Elizabeth
    Iyengar, Smriti
    Johansson, Anette M.
    ACS MEDICINAL CHEMISTRY LETTERS, 2013, 4 (06): : 560 - 564
  • [9] Selective serotonin and norepinephrine reuptake inhibitors (SSNRI) -: antidepressants with a dual mode of action
    Müller, WE
    Haen, E
    Fritze, J
    Rüther, E
    Laux, G
    Bauer, M
    Möller, HJ
    PSYCHOPHARMAKOTHERAPIE, 2004, 11 (03): : 71 - 75
  • [10] THE PRESCRIPTION PATTERNS OF SELECTIVE SEROTONIN (NOREPINEPHRINE) REUPTAKE INHIBITORS IN GERMANY
    Kap, E. J.
    Konrad, M.
    Bohlken, J.
    Kostev, K.
    VALUE IN HEALTH, 2018, 21 : S278 - S278